Chemical conjugation of aptamer–sphingomyelin nanosystems and their potential as inhibitors of tumour cell proliferation in breast cancer cells

Abstract

Sphingomyelin nanoemulsions were covalently conjugated with apMNK2F using a 2-step bioconjugation process. They demonstrated effective intracellular delivery, outperforming free aptamer, resulting in decreased breast cancer cell proliferation.